Author: BusinessWire

May 30, 2019 Off

OptiKira Awarded Phase II SBIR Grant

By BusinessWire

Grant will support development of a new treatment for retinitis pigmentosa CLEVELAND–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/BioMotiv?src=hash" target="_blank"gt;#BioMotivlt;/agt;–OptiKira, LLC, a privately-held biotechnology company…